Pauls Matthew — SEC Form 4 filings
SEC reporting owner CIK 1573429. 13 Form 4 filings on record with FilingPulse; latest filed 2026-07-07.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-06-10 to 2026-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 4 filings — 62,211 shares, $642,626 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 5,937 shares @ $71.55 ($424,797) in SOLENO THERAPEUTICS INC, filed 2025-03-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC (SLNO) | Director | 4 | — | 1 leg · 5,937 sh · $424,797 | 6 |
| Savara Inc (SVRA) | CHIEF EXECUTIVE OFFICER, Director | 3 | — | 1 leg · 54,702 sh · $180,828 | 6 |
| Pelthos Therapeutics Inc. (PTHS) | Director | 5 | — | 4 legs · 1,572 sh · $37,001 | 8 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | Director | 1 | — | — | 1 |
Form 4 filings — Pauls Matthew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | Pelthos Therapeutics Inc. (PTHS) | Sale (S): 692 @ $26.00 · Sale (S): 94 @ $27.36 | EDGAR |
| 2026-07-01 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Disposition to issuer (D): 10,491 · Disposition to issuer (D): 9,063 (derivative) | EDGAR |
| 2026-04-06 | 4 | Pelthos Therapeutics Inc. (PTHS) | Sale (S): 415 @ $20.52 · Sale (S): 371 @ $21.36 | EDGAR |
| 2026-04-01 | 4/A | Pelthos Therapeutics Inc. (PTHS) | Grant/award (A): 25,478 @ $0 | EDGAR |
| 2025-12-16 | 4 | Savara Inc (SVRA) | Tax withholding (F): 195,705 @ $6.92 · Gift (G): 128,995 @ $0 | EDGAR |
| 2025-12-12 | 4 | Pelthos Therapeutics Inc. (PTHS) | Option exercise (M): 8,493 @ $0 · Option exercise (M): 2,123 @ $0 · Gift (G): 9,542 @ $0 · Option exercise (M): 8,493 (derivative) @ $0 · Option exercise (M): 2,123 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Savara Inc (SVRA) | Gift (G): 23,629 @ $0 | EDGAR |
| 2025-07-07 | 4 | Pelthos Therapeutics Inc. (PTHS) | Grant/award (A): 25,478 (derivative) · Grant/award (A): 77,640 (derivative) | EDGAR |
| 2025-06-09 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Grant/award (A): 3,991 @ $0 | EDGAR |
| 2025-03-31 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Option exercise (M): 5,937 @ $4.60 · Sale (S): 5,937 @ $71.55 · Option exercise (M): 5,937 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Savara Inc (SVRA) | Grant/award (A): 400,000 @ $0 · Tax withholding (F): 92,593 @ $3.21 · Sale (S): 54,702 @ $3.31 · Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Grant/award (A): 6,500 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1573429 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →